News Archive

EMA - Stakeholder engagement biennial report 2020-2021 and highlights of stakeholder activities in 2021

18th May 2022

From the EMA Stakeholder engagement biennial report 2020-2021 and highlights of stakeholder activities in 2021 We are pleased to inform you that the biennial stakeholder engagement report has been published, along with the highlights of stakeholder activities in 2021. This report provides a high-level overview of EMA's engagement with patients, consumers, healthcare professionals and academia and different activities where they have been involved.  EMA would like to thank all stakeholders involved in activities during these two challenging years. This biennial report has also been shared by social media, the links are below:

Read More+

MHRA - policy for handling conflicts of interest

18th May 2022

MHRA: policy for handling conflicts of interest - Uploaded the annual conflict of interest compliance report - 2021

Read More+

MHRA - Drug Safety Update

18th May 2022

MHRA - Uploaded the Drug Safety Update for May 2022

Read More+

WHO - launches first ever global report on infection prevention and control

18th May 2022

WHO launches first ever global report on infection prevention and control

Read More+

MHRA Blog - Compliance Monitor Process (Part 2)– CM role and application process

11th May 2022

Compliance Monitor Process (Part 2)– CM role and application process - a new blog post from the MHRA.

Read More+

EMA - CTIS newsflash #11 - 22 April 2022

4th May 2022

EMA - CTIS newsflash #11 - 22 April 2022

Read More+

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022

4th May 2022

EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 April 2022

Read More+

EMA - Overview of comments on on ICH guideline Q9 (R1) on quality risk management

4th May 2022

EMA have provided an overview of comments received between December 2021 and March 2022 on on ICH guideline Q9 (R1) on quality risk management.

Read More+

MHRA - Compliance Monitor (CM) Overview and Application Process

4th May 2022

From April 2022, the MHRA will be running a pilot scheme to monitor companies that fail to comply with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) and are referred to the Inspection Action Group (IAG) after an inspection that has resulted in the compliance escalation process being initiated.

Read More+

EMA - Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022

19th April 2022

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 4-7 April 2022

Read More+